3.12
+0.165(+5.59%)
Currency In USD
| Previous Close | 2.95 |
| Open | 2.99 |
| Day High | 3.16 |
| Day Low | 2.97 |
| 52-Week High | 8.94 |
| 52-Week Low | 1.8 |
| Volume | 118,494 |
| Average Volume | 249,083 |
| Market Cap | 49.63M |
| PE | -2.27 |
| EPS | -1.37 |
| Moving Average 50 Days | 4.05 |
| Moving Average 200 Days | 3.35 |
| Change | 0.17 |
Medicus Pharma Ltd Announces a Definitive Agreement to Acquire Antev Ltd. UK
Newsfile
Jun 30, 2025 11:30 AM GMT
Antev Shareholders to Receive Aggregate ~17% Equity Stake in Medicus plus US$65 Million in Contingent PaymentsPhiladelphia, Pennsylvania--(Newsfile Corp. - June 30, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus") and Antev Ltd. ("Antev"), a UK
Medicus Pharma Ltd. Announces Appointment of Andrew Smith as Chief Operating Officer
Newsfile
Jun 23, 2025 11:30 AM GMT
Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Basal Cell Carcinoma (BCC) Using Novel Doxorubicin Containing Microneedle Arrays (D-MNA)Philadelphia, Pennsylvania--(Newsfile Corp. - June 23, 2025) - Medicus Pharma Ltd. (NASD
Medicus Pharma Ltd. to Present at 2025 Bio International Convention
Newsfile
Jun 12, 2025 11:30 AM GMT
Company Executive Chairman & CEO to Provide Corporate Updates on June 17th 2025Philadelphia, Pennsylvania--(Newsfile Corp. - June 12, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is pleased to announce the schedule of the p